Australia markets closed

Axon Enterprise, Inc. (AXON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
308.45+2.78 (+0.91%)
At close: 04:00PM EDT
308.00 -0.45 (-0.15%)
After hours: 07:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close305.67
Bid308.24 x 100
Ask308.74 x 100
Day's range304.16 - 310.49
52-week range175.37 - 329.87
Avg. volume511,993
Market cap23.278B
Beta (5Y monthly)0.95
PE ratio (TTM)90.19
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    United States Marshals Service to adopt TASER 10 and companion virtual reality training solutions

    Axon (Nasdaq: AXON), the global public safety technology leader, today announced that the United States Marshals Service (USMS) has deployed Axon's next-gen less-lethal energy weapon, TASER 10. The USMS will also be piloting Axon's VR Training solution to support the deployment of TASER 10 and to provide more affordable and accessible training across a variety of immersive real-world scenarios.

  • PR Newswire

    Axon and Skydio partner to deliver scalable drone offering for public safety, including Drone as First Responder solution

    Axon (Nasdaq: AXON), the global public safety technology leader, and Skydio, the leading U.S. drone manufacturer and the world leader in autonomous flight, announced today the launch of an end-to-end offering for drones in public safety, including a scalable Drone as First Responder (DFR) solution.

  • GlobeNewswire

    Oncocyte Appoints Andrea James as Chief Financial Officer

    IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer. “We are thrilled to welcome Andrea as we approach the inflection point of commercial launch,” Oncocyte CEO Josh Riggs said. “She has a proven track record of guiding financial strategy through multiple phases of growth, raising and stewarding capital, and bu